Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Questions & Answers on Ocumension Therapeutics, Nicox’s commercial partner for NCX 470 in China

September 11, 2026

View Press Release Corporate presentation Contact us
Previous